BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16187883)

  • 1. Visual-perceptual dysfunctions are possible endophenotypes of schizophrenia: evidence from the psychophysical investigation of magnocellular and parvocellular pathways.
    Kéri S; Kelemen O; Janka Z; Benedek G
    Neuropsychology; 2005 Sep; 19(5):649-656. PubMed ID: 16187883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vernier threshold in patients with schizophrenia and in their unaffected siblings.
    Kéri S; Kelemen O; Benedek G; Janka Z
    Neuropsychology; 2004 Jul; 18(3):537-42. PubMed ID: 15291731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia.
    Cimmer C; Szendi I; Csifcsák G; Szekeres G; Ambrus Kovács Z; Somogyi I; Benedek G; Janka Z; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1225-30. PubMed ID: 16644085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrafoveally applied flashing light affects contrast thresholds of achromatic and S-cone isolating, but not L-M cone modulated stimuli.
    Őze A; Puszta A; Buzás P; Kóbor P; Braunitzer G; Nagy A
    Neurosci Lett; 2018 Jun; 678():99-103. PubMed ID: 29751069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct?
    Kéri S; Kiss I; Kelemen O; Benedek G; Janka Z
    Psychol Med; 2005 Oct; 35(10):1445-55. PubMed ID: 16164768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychophysical assessment of magno- and parvocellular function in schizophrenia.
    Delord S; Ducato MG; Pins D; Devinck F; Thomas P; Boucart M; Knoblauch K
    Vis Neurosci; 2006; 23(3-4):645-50. PubMed ID: 16962008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensory contributions to impaired emotion processing in schizophrenia.
    Butler PD; Abeles IY; Weiskopf NG; Tambini A; Jalbrzikowski M; Legatt ME; Zemon V; Loughead J; Gur RC; Javitt DC
    Schizophr Bull; 2009 Nov; 35(6):1095-107. PubMed ID: 19793797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia.
    Schechter I; Butler PD; Silipo G; Zemon V; Javitt DC
    Schizophr Res; 2003 Nov; 64(2-3):91-101. PubMed ID: 14613674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia.
    Schechter I; Butler PD; Zemon VM; Revheim N; Saperstein AM; Jalbrzikowski M; Pasternak R; Silipo G; Javitt DC
    Clin Neurophysiol; 2005 Sep; 116(9):2204-15. PubMed ID: 16055375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
    Kelemen O; Kiss I; Benedek G; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vernier threshold and the parallel visual pathways in bipolar disorder: a follow-up study.
    Kéri S; Benedek G; Janka Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):86-91. PubMed ID: 16901599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments.
    Butler PD; Martinez A; Foxe JJ; Kim D; Zemon V; Silipo G; Mahoney J; Shpaner M; Jalbrzikowski M; Javitt DC
    Brain; 2007 Feb; 130(Pt 2):417-30. PubMed ID: 16984902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of early-stage visual processing in schizophrenia.
    Butler PD; Schechter I; Zemon V; Schwartz SG; Greenstein VC; Gordon J; Schroeder CE; Javitt DC
    Am J Psychiatry; 2001 Jul; 158(7):1126-33. PubMed ID: 11431235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feature uncertainty: a novel test to probe prefrontal dysfunction in unaffected siblings of schizophrenia patients.
    Kéri S; Gulyás B; Benedek G; Janka Z
    Neurosci Lett; 2005 Feb; 375(1):33-6. PubMed ID: 15664118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level, but not low-level, motion perception is impaired in patients with schizophrenia.
    Kandil FI; Pedersen A; Wehnes J; Ohrmann P
    Neuropsychology; 2013 Jan; 27(1):60-8. PubMed ID: 23356597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia and red light: fMRI evidence for a novel biobehavioral marker.
    Bedwell JS; Miller LS; Brown JM; Yanasak NE
    Int J Neurosci; 2006 Aug; 116(8):881-94. PubMed ID: 16861153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does the hippocampal formation mediate memory for stimuli processed by the magnocellular and parvocellular visual pathways? Evidence from the comparison of schizophrenia and amnestic mild cognitive impairment (aMCI).
    Kéri S; Szamosi A; Benedek G; Kelemen O
    Neuropsychologia; 2012 Dec; 50(14):3193-9. PubMed ID: 23085125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast sensitivity for motion detection and direction discrimination in adolescents with autism spectrum disorders and their siblings.
    Koh HC; Milne E; Dobkins K
    Neuropsychologia; 2010 Dec; 48(14):4046-56. PubMed ID: 20937290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient visual sensitivity in schizotypal personality disorder.
    Kent BW; Weinstein ZA; Passarelli V; Chen Y; Siever LJ
    Schizophr Res; 2011 Apr; 127(1-3):144-50. PubMed ID: 20541911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnocellular and parvocellular visual pathway contributions to visual field anisotropies.
    McAnany JJ; Levine MW
    Vision Res; 2007 Aug; 47(17):2327-36. PubMed ID: 17662333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.